Publications by authors named "Nancy Alvandi"

Claim this Profile
O
Oxymetazoline and Energy-Based Therapy in Patients with Rosacea: Evaluation of the Safety and Tolerability in an Open-Label, Interventional Study.
Emil A Tanghetti, David J Goldberg, Jeffrey S Dover, Roy G Geronemus, Zane Bai, Nancy Alvandi

Lasers Surg Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insight into the activity of a sulfone compound dapsone on Propionibacterium (Newly Reclassified as Cutibacterium) Acnes-mediated cytokine production.
Mikhail Geyfman, Dmitri Debabov, Neil Poloso, Nancy Alvandi

Exp Dermatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
George Zhanel, Ian Critchley, Lynn-Yao Lin, Nancy Alvandi

Antimicrob Agents Chemother· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
Emil Tanghetti, Julie Harper, Hilary Baldwin, Leon Kircik, Zhanying Bai, Nancy Alvandi

J Drugs Dermatol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
Emil Tanghetti, Julie Harper, Hilary Baldwin, Leon Kircik, Zhanying Bai, Nancy Alvandi

J Drugs Dermatol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
Emil Tanghetti, Julie Harper, Hilary Baldwin, Leon Kircik, Zhanying Bai, Nancy Alvandi

J Drugs Dermatol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials.
Linda Stein-Gold, Leon Kircik, Zoe Diana Draelos, Philip Werschler, Janet DuBois, Nancy Alvandi

J Drugs Dermatol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings.
Michael Kennelly, Lonny Green, Nancy Alvandi, Salim Wehbe, John Joseph Smith

Curr Med Res Opin· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatment.
Michael H Gold, Mark Lebwohl, Brian S Biesman, Deanne Mraz Robinson, Lei Luo, Nancy Alvandi

J Am Acad Dermatol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.
Zoe Diana Draelos, Michael H Gold, Robert A Weiss, Leslie Baumann, Steven K Grekin, Nancy Alvandi

J Am Acad Dermatol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Experience With Once-Daily Dapsone Gel, 7.5% Monotherapy in Patients With Acne Vulgaris.
Toni C Stockton, Emil A Tanghetti, Edward Lain, Joshua A Zeichner, Nancy Alvandi

J Drugs Dermatol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.
Emil A Tanghetti, Jeffrey S Dover, David J Goldberg, Sunil S Dhawan, Lei Luo, Nancy Alvandi

J Drugs Dermatol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype.
Susan C Taylor, Fran E Cook-Bolden, Amy McMichael, Jeanine B Downie, David A Rodriguez, Nancy Alvandi

J Drugs Dermatol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials.
Linda Stein-Gold, Leon H Kircik, Zoe Diane Draelos, Philip Werschler, Janet DuBois, Nancy Alvandi

J Am Acad Dermatol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis